Table 3. CTE-Related Outcomes According to CDAI Group.

Outcomes	CDAI < 150 (n = 51)	CDAI ≥ 150 (n = 37)	Univariable P†	Multivariable Adjusted P‡
Diagnostic yield of CTE (%)
CD recurrence in the anastomotic region	19/51 (37.3)	12/37 (32.4)	0.659	0.623
Extraluminal penetrating complications	2/51 (3.9)	6/37 (16.2)	0.065	0.029
CTE-related step-up therapy (%)*	10/51 (19.6)	8/37 (21.6)	1.000	0.826
Step-up therapy performed	9/51 (17.6)	8/37 (21.6)
Step-up therapy decided but patient declined	1/51 (2.0)	0/37 (0.0)

Number in parentheses is percentage. ^*Step-up therapy that followed detection of anastomotic recurrence on CTE, ^†Obtained with Fisher exact test, ^‡Obtained with multiple logistic regression by adjusting for active smoking, penetrating disease, and previous CD-related bowel resection.